Literature DB >> 8837543

Prevention and management of osteoporosis: consensus statements from the Scientific Advisory Board of the Osteoporosis Society of Canada. 4. Calcium nutrition and osteoporosis.

T M Murray1.   

Abstract

OBJECTIVE: To recommend appropriate levels of calcium intake in light of the most recent studies. OPTIONS: Dietary calcium intake, calcium supplementation, calcium and vitamin D supplementation; ovarian hormone therapy in postmenopausal women. OUTCOMES: Fracture and loss of bone mineral density in osteoporosis; increased bone mass, prevention of fractures and improved quality of life associated with osteoporosis prevention. EVIDENCE: Relevant clinical studies and reports were examined, in particular those published since the 1988 Osteoporosis Society of Canada position paper on calcium nutrition. Only studies in humans were considered, including controlled, randomized trials and prospective studies, using bone mass and fractures as end-points. Studies in early and later phases of skeletal growth were noted. The analysis was designed to eliminate menopause as a confounding variable. VALUES: Preventing osteoporosis and maximizing quality of life were given a high value. BENEFITS, HARMS AND COSTS: Adequate calcium nutrition increases bone mineral density during skeletal growth and prevents bone loss and osteoporotic fractures in the elderly. Risks associated with high dietary calcium intake are low, and a recent study extends this conclusion to the risk of kidney stones. Lactase-deficient patients may substitute yogurt and lactase-treated milk for cow's milk. True milk allergy is probably rare; its promotion of diabetes mellitus in susceptible people is being studied. RECOMMENDATIONS: Current recommended intakes of calcium are too low. Revised intake guidelines designed to reduce bone loss and protect against osteoporotic fractures are suggested. Canadians should attempt to meet their calcium requirements principally through food sources. Pharmaceutical calcium supplements and a dietician's advice should be considered where dietary preferences or lactase deficiency restrict consumption of dairy foods. Further research is necessary before recommending the general use of calcium supplements by adolescents. Calcium supplementation cannot substitute for hormone therapy in the prevention of postmenopausal bone loss and fractures. Adequate amounts of vitamin D are necessary for optimal calcium absorption and bone health. Elderly people and those who use heavy sun screens should have a dietary intake of 400 to 800 IU of vitamin D per day.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8837543      PMCID: PMC1335457     

Source DB:  PubMed          Journal:  CMAJ        ISSN: 0820-3946            Impact factor:   8.262


  26 in total

1.  Calcium intake and peak bone mass.

Authors:  V Matkovic
Journal:  N Engl J Med       Date:  1992-07-09       Impact factor: 91.245

2.  Calcium balance during human growth: evidence for threshold behavior.

Authors:  V Matkovic; R P Heaney
Journal:  Am J Clin Nutr       Date:  1992-05       Impact factor: 7.045

3.  Postmenopausal bone loss is prevented by treatment with low-dosage estrogen with calcium.

Authors:  B Ettinger; H K Genant; C E Cann
Journal:  Ann Intern Med       Date:  1987-01       Impact factor: 25.391

4.  Milk consumption and bone mineral density in middle aged and elderly women.

Authors:  S Murphy; K T Khaw; H May; J E Compston
Journal:  BMJ       Date:  1994-04-09

5.  Calcium supplementation and increases in bone mineral density in children.

Authors:  C C Johnston; J Z Miller; C W Slemenda; T K Reister; S Hui; J C Christian; M Peacock
Journal:  N Engl J Med       Date:  1992-07-09       Impact factor: 91.245

6.  Vitamin D3 and calcium to prevent hip fractures in elderly women.

Authors:  M C Chapuy; M E Arlot; F Duboeuf; J Brun; B Crouzet; S Arnaud; P D Delmas; P J Meunier
Journal:  N Engl J Med       Date:  1992-12-03       Impact factor: 91.245

7.  Does calcium supplementation prevent postmenopausal bone loss? A double-blind, controlled clinical study.

Authors:  B Riis; K Thomsen; C Christiansen
Journal:  N Engl J Med       Date:  1987-01-22       Impact factor: 91.245

8.  Bone gain in young adult women.

Authors:  R R Recker; K M Davies; S M Hinders; R P Heaney; M R Stegman; D B Kimmel
Journal:  JAMA       Date:  1992-11-04       Impact factor: 56.272

9.  Menopausal changes in calcium balance performance.

Authors:  R P Heaney; R R Recker; P D Saville
Journal:  J Lab Clin Med       Date:  1978-12

10.  Effect of calcium supplementation on bone loss in postmenopausal women.

Authors:  I R Reid; R W Ames; M C Evans; G D Gamble; S J Sharpe
Journal:  N Engl J Med       Date:  1993-02-18       Impact factor: 91.245

View more
  6 in total

Review 1.  Current knowledge about physiotherapeutic strategies in osteoporosis prevention and treatment.

Authors:  U Lange; J Teichmann; C Uhlemann
Journal:  Rheumatol Int       Date:  2004-11-27       Impact factor: 2.631

2.  Treatment for older men with fractures.

Authors:  A J Shepherd; A R Cass; L A Ray; A Tan; G S Wilkinson
Journal:  Osteoporos Int       Date:  2011-08-03       Impact factor: 4.507

3.  Current and projected rates of hip fracture in Canada.

Authors:  E A Papadimitropoulos; P C Coyte; R G Josse; C E Greenwood
Journal:  CMAJ       Date:  1997-11-15       Impact factor: 8.262

4.  PKU patients on a relaxed diet may be at risk for micronutrient deficiencies.

Authors:  C Rohde; A von Teeffelen-Heithoff; A G Thiele; M Arelin; U Mütze; C Kiener; J Gerloff; C Baerwald; S Schultz; C Heller; A S Müller; W Kiess; S Beblo
Journal:  Eur J Clin Nutr       Date:  2013-11-20       Impact factor: 4.016

5.  Alendronate for osteoporosis. Safe and efficacious nonhormonal therapy.

Authors:  J D Adachi
Journal:  Can Fam Physician       Date:  1998-02       Impact factor: 3.275

6.  Women's perceptions of future risk after low-energy fractures at midlife.

Authors:  Lynn M Meadows; Linda Mrkonjic; Laura Lagendyk
Journal:  Ann Fam Med       Date:  2005 Jan-Feb       Impact factor: 5.166

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.